Innate lymphoid cells and allergic desease
Annals of Allergy, Asthma & Immunology
December 2017 Volume 119, Issue 6, Pages 480-488 CME Review
Accreditation: The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation: The American College of Allergy, Asthma & Immunology (ACAAI) designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Planning Committee Members:
Matthew T. Stier, PhD (Author)
Ray Stokes Peebles, Jr. MD (Author)
Jonathan A. Bernstein, MD (Annals CME Subcommittee)
Guha Krishnaswamy, MD (Annals CME Subcommittee)
John J. Oppenheimer, MD (Annals CME Subcommittee, Associate Editor)
Mitchell H. Grayson, MD (CME Series Editor, Deputy Editor)
Gailen D. Marshall, Jr, MD, PhD (Editor-in-Chief)
Target Audience
Physicians involved in providing patient care in the field of allergy/asthma/immunology
Learning Objectives
At the conclusion of this activity, participants should be able to:
Describe the variety of innate lymphoid cells (ILC), their major functions, their development, and their role in the pathogenesis of allergic disease.
Dicuss the correlations between ILC and human allergic disease, especially in regard to ILC numbers, activation state, and cytokine production.
Accreditation: The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation: The American College of Allergy, Asthma & Immunology (ACAAI) designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Available Credit
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Attendance